These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
3. Experience with indium-111 and yttrium-90-labeled somatostatin analogs. Virgolini I; Traub T; Novotny C; Leimer M; Füger B; Li SR; Patri P; Pangerl T; Angelberger P; Raderer M; Burggasser G; Andreae F; Kurtaran A; Dudczak R Curr Pharm Des; 2002; 8(20):1781-807. PubMed ID: 12171531 [TBL] [Abstract][Full Text] [Related]
4. New trends in peptide receptor radioligands. Virgolini I; Traub T; Novotny C; Leimer M; Füger B; Li SR; Patri P; Pangerl T; Angelberger P; Raderer M; Andreae F; Kurtaran A; Dudczak R Q J Nucl Med; 2001 Jun; 45(2):153-9. PubMed ID: 11476164 [TBL] [Abstract][Full Text] [Related]
5. In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen. Smith-Jones PM; Vallabahajosula S; Goldsmith SJ; Navarro V; Hunter CJ; Bastidas D; Bander NH Cancer Res; 2000 Sep; 60(18):5237-43. PubMed ID: 11016653 [TBL] [Abstract][Full Text] [Related]
6. Biological and clinical perspectives of cancer imaging and therapy with radiolabeled antibodies. Goldenberg DM; Blumenthal RD; Sharkey RM Semin Cancer Biol; 1990 Jun; 1(3):217-25. PubMed ID: 2103497 [TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of mono- and multimeric targeted radiopharmaceuticals based on novel cyclen ligands coupled to anti-MUC1 aptamers for the diagnostic imaging and targeted radiotherapy of cancer. Borbas KE; Ferreira CS; Perkins A; Bruce JI; Missailidis S Bioconjug Chem; 2007; 18(4):1205-12. PubMed ID: 17583928 [TBL] [Abstract][Full Text] [Related]
8. Lymphoma, melanoma, colon cancer: diagnosis and treatment with radiolabeled monoclonal antibodies. The 1986 Eugene P. Pendergrass New Horizons Lecture. Larson SM Radiology; 1987 Nov; 165(2):297-304. PubMed ID: 3498971 [TBL] [Abstract][Full Text] [Related]
10. Tumor localization using radiolabeled monoclonal antibodies. An overview. Zalcberg JR Am J Clin Oncol; 1985 Dec; 8(6):481-9. PubMed ID: 3909809 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody SEN7 recognizes a new epitope on the neural cell adhesion molecule present on small cell lung cancer but not on lymphocytes. Waibel R; Mannhart M; O'Hara CJ; Brocklehurst C; Zangemeister-Wittke U; Schenker T; Lehmann HP; Weber E; Stahel RA Cancer Res; 1993 Jun; 53(12):2840-5. PubMed ID: 7684948 [TBL] [Abstract][Full Text] [Related]
12. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels. Shockley TR; Lin K; Sung C; Nagy JA; Tompkins RG; Dedrick RL; Dvorak HF; Yarmush ML Cancer Res; 1992 Jan; 52(2):357-66. PubMed ID: 1728407 [TBL] [Abstract][Full Text] [Related]
13. Imaging of human tumor xenografts in nude mice with radiolabeled monoclonal antibodies. Limitations of specificity due to nonspecific uptake of antibody. Mann BD; Cohen MB; Saxton RE; Morton DL; Benedict WF; Korn EL; Spolter L; Graham LS; Chang CC; Burk MW Cancer; 1984 Oct; 54(7):1318-27. PubMed ID: 6467157 [TBL] [Abstract][Full Text] [Related]
14. Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors. Laverman P; Béhé M; Oyen WJ; Willems PH; Corstens FH; Behr TM; Boerman OC Bioconjug Chem; 2004; 15(3):561-8. PubMed ID: 15149184 [TBL] [Abstract][Full Text] [Related]
15. The macroscopic and microscopic pharmacology of monoclonal antibodies. Weinstein JN; van Osdol W Int J Immunopharmacol; 1992 Apr; 14(3):457-63. PubMed ID: 1618598 [TBL] [Abstract][Full Text] [Related]
16. Gene expression imaging with radiolabeled peptides. Buchsbaum DJ; Chaudhuri TR; Yamamoto M; Zinn KR Ann Nucl Med; 2004 Jun; 18(4):275-83. PubMed ID: 15359919 [TBL] [Abstract][Full Text] [Related]
17. Binding of EGF peptide and EGF receptor antibodies and its fragments in different tumor models. Senekowitsch-Schmidtke R Hybridoma; 1999 Feb; 18(1):29-35. PubMed ID: 10211785 [TBL] [Abstract][Full Text] [Related]
18. Semiquantitative in vitro binding assay of indium-111-labeled monoclonal antibodies to human cancer and normal tissues. Watanabe Y; Endo K; Koizumi M; Sakahara H; Kawamura Y; Saga T; Konishi J; Ohshio G; Manabe T; Tobe R J Nucl Med; 1988 Aug; 29(8):1436-42. PubMed ID: 3042924 [TBL] [Abstract][Full Text] [Related]
19. Molecular Simulation of Receptor Occupancy and Tumor Penetration of an Antibody and Smaller Scaffolds: Application to Molecular Imaging. Orcutt KD; Adams GP; Wu AM; Silva MD; Harwell C; Hoppin J; Matsumura M; Kotsuma M; Greenberg J; Scott AM; Beckman RA Mol Imaging Biol; 2017 Oct; 19(5):656-664. PubMed ID: 28213834 [TBL] [Abstract][Full Text] [Related]
20. Methods for the study of the metabolism of radiolabeled monoclonal antibodies by liver and tumor. Sands H; Jones PL J Nucl Med; 1987 Mar; 28(3):390-8. PubMed ID: 3546629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]